Proposed Data Collection Submitted for Public Comment and Recommendations, 6554-6555 [2022-02404]
Download as PDF
<![CDATA[
6554
Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–02399 Filed 2–3–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–20MR; Docket No. CDC–2022–
0018]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Leptospirosis and Melioidosis
Active Hospital-based Surveillance in
Puerto Rico. The project aims to identify
leptospirosis and melioidosis cases in
Puerto Rico by establishing active
surveillance for both diseases at four
hospital sites for disease identification
and treatment and to improve
understanding of leptospirosis and
melioidosis epidemiology and ecology
in Puerto Rico for public health control
and prevention planning.
DATES: CDC must receive written
comments on or before April 5, 2022.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0018 by either of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
Proposed Project
Leptospirosis and Melioidosis Active
Hospital-based Surveillance in Puerto
Rico—Existing Collection in Use
Without an OMB Control Number—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
This project aims to identify
leptospirosis and melioidosis cases in
Puerto Rico by establishing active
surveillance for both diseases at four
hospital sites for timely disease
identification and treatment and to
improve understanding of leptospirosis
and melioidosis epidemiology and
ecology in Puerto Rico for public health
control and prevention planning. Both
diseases can cause outbreaks after
hurricanes and flooding, especially in
tropical areas, and this project is being
conducted in response to an increase in
leptospirosis cases after Hurricanes Irma
and Maria in 2017.
Participants will be recruited from the
population presenting to the emergency
department of the four hospital sites
with febrile illness, and will be
interviewed to gather information on
symptoms, possible exposures, and
medical history, in addition to having
diagnostic samples collected to test for
leptospirosis plus or minus melioidosis
(depending on presenting symptoms).
Participants will also be interviewed
approximately two weeks after
enrollment to determine illness
progression and outcome. Patients
testing positive for leptospirosis, if
willing, may have animal samples taken
from their home or work environments
to help determine the animal reservoirs
related to human leptospirosis illness in
Puerto Rico.
CDC requests OMB approval for an
estimated 1,675 annual burden hours.
There is no cost to respondents other
than their time to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of respondents
Patient .............................
PIFA (screening) ................................
Up to 7,000 ....................
VerDate Sep<11>2014
18:50 Feb 03, 2022
Jkt 256001
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
E:\FR\FM\04FEN1.SGM
1
04FEN1
Average
burden per
response
(in hours)
5/60
Total burden
(in hours)
583
6555
Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Patient
Patient
Patient
Patient
Form name
Total burden
(in hours)
PIFA (full form: sections 1–4, 11) ......
Consent Form ....................................
PIFF ...................................................
Animal Household Survey .................
Up
Up
Up
Up
3,000 ....................
3,000 ....................
1,000 ....................
250 .......................
1
1
1
1
10/60
6/60
10/60
30/60
500
300
167
125
Total .........................
............................................................
........................................
........................
........................
1,675
[FR Doc. 2022–02404 Filed 2–3–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–1014]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled CDC Worksite
Health ScoreCard (CDC ScoreCard) to
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on September 27, 2021 to obtain
comments from the public and affected
agencies. CDC received two comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
VerDate Sep<11>2014
18:50 Feb 03, 2022
Jkt 256001
to
to
to
to
Average
burden per
response
(in hours)
.............................
.............................
.............................
.............................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Number of respondents
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
CDC Worksite Health ScoreCard (CDC
ScoreCard) (OMB Control No. 0920–
1014, Exp. 3/31/2022)—Extension—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) has established the
Worksite Health ScoreCard (CDC
ScoreCard), an online organizational
assessment tool, to enable employers to
assess the number of evidence-based
health promotion interventions or
strategies in their worksites to promote
employee health and well-being.
The CDC ScoreCard will support
small, mid-size, and large employers
with three primary goals: (1) Assist
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
employers in identifying gaps in their
health promotion programs, and help
them to prioritize high-impact strategies
for health promotion at their worksites;
(2) Improve the health and wellbeing of
employees and their families through
science-based workplace health
interventions and promising practices;
and (3) Support research and increase
understanding of the organizational
programs, policies, and practices that
employers of various sizes and industry
sectors have implemented to support
healthy lifestyle behaviors.
CDC is requesting an extension to a
previously approved data collection
enabling existing employer users as well
as new users to continue to have access
to the CDC ScoreCard web-based
organizational assessment tool
(available at https://www.cdc.gov/
healthscorecard).
CDC will provide outreach to, and
register approximately 800 employers
per year to use the online survey, which
is open to employers of all sizes,
industry sectors, and geographic
locations across the country. CDC
ScoreCard users will create a user
account, complete the online
assessment and receive an immediate
feedback report that summarizes the
current status of their worksite health
program; identifies gaps in current
programming; benchmarks individual
employer results against other users of
the system; and provides access to
worksite health tools and resources to
address employer gaps and priority
program areas.
CDC will use the information
collected to evaluate the effectiveness of
the CDC ScoreCard in terms of (1)
identifying success drivers for building
and maintaining successful workplace
health programs; (2) raising awareness
and knowledge of science-based
worksite health programs, policies and
practices; and (3) developing additional
worksite health tools and resources for
employers. The information will also be
used to evaluate the impact of the CDC
Worksite Health Scorecard on employer
adoption of worksite health programs,
policies, and environmental supports.
E:\FR\FM\04FEN1.SGM
04FEN1
]]>Agencies
[Federal Register Volume 87, Number 24 (Friday, February 4, 2022)]
[Notices]
[Pages 6554-6555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02404]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-20MR; Docket No. CDC-2022-0018]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Leptospirosis and Melioidosis
Active Hospital-based Surveillance in Puerto Rico. The project aims to
identify leptospirosis and melioidosis cases in Puerto Rico by
establishing active surveillance for both diseases at four hospital
sites for disease identification and treatment and to improve
understanding of leptospirosis and melioidosis epidemiology and ecology
in Puerto Rico for public health control and prevention planning.
DATES: CDC must receive written comments on or before April 5, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0018 by either of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Leptospirosis and Melioidosis Active Hospital-based Surveillance in
Puerto Rico--Existing Collection in Use Without an OMB Control Number--
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
This project aims to identify leptospirosis and melioidosis cases
in Puerto Rico by establishing active surveillance for both diseases at
four hospital sites for timely disease identification and treatment and
to improve understanding of leptospirosis and melioidosis epidemiology
and ecology in Puerto Rico for public health control and prevention
planning. Both diseases can cause outbreaks after hurricanes and
flooding, especially in tropical areas, and this project is being
conducted in response to an increase in leptospirosis cases after
Hurricanes Irma and Maria in 2017.
Participants will be recruited from the population presenting to
the emergency department of the four hospital sites with febrile
illness, and will be interviewed to gather information on symptoms,
possible exposures, and medical history, in addition to having
diagnostic samples collected to test for leptospirosis plus or minus
melioidosis (depending on presenting symptoms). Participants will also
be interviewed approximately two weeks after enrollment to determine
illness progression and outcome. Patients testing positive for
leptospirosis, if willing, may have animal samples taken from their
home or work environments to help determine the animal reservoirs
related to human leptospirosis illness in Puerto Rico.
CDC requests OMB approval for an estimated 1,675 annual burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Patient...................... PIFA (screening) Up to 7,000.... 1 5/60 583
[[Page 6555]]
Patient...................... PIFA (full form: Up to 3,000.... 1 10/60 500
sections 1-4,
11).
Patient...................... Consent Form.... Up to 3,000.... 1 6/60 300
Patient...................... PIFF............ Up to 1,000.... 1 10/60 167
Patient...................... Animal Household Up to 250...... 1 30/60 125
Survey.
-----------------------------------------------
Total.................... ................ ............... .............. .............. 1,675
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-02404 Filed 2-3-22; 8:45 am]
BILLING CODE 4163-18-P
